C

Cerus Corp

D
CERS
USD
-0.035
(-1.9499%)
Market Closed
196,711.00
Volume
-0.32
EPS
-
Div Yield
-13.538462
P/E
326,123,086.08
Market Cap
Today
1.7341%
1 Week
12.460%
1 Month
2.924%
6 Months
-4.865%
12 Months
1.734%
Year To Date
-18.707%
All Time
-71.613%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
T
TDOC
0.09
(0.9554%)
USD
A
ADPT
-0.11
(-1.9164%)
USD
N
NTRA
5.925
(4.7636%)
USD
P
PSTG
-0.11
(-0.2035%)
USD
REGN
REGN
8.505
(1.0417%)
USD
ABBV
ABBV
-4.79
(-2.3337%)
USD
MRNA
MRNA
-0.985
(-1.921%)
USD
M
MRTX
(%)
USD
C
CRSP
1.04
(2.0444%)
USD
E
EDIT
-0.11
(-3.3537%)
USD

Title:
Cerus Corp

Sector:
Healthcare
Industry:
Medical Devices
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
Do you need help or have a question?
Contact Us